(Press-News.org) The rapid adoption of AI and big data technologies in the biotechnology sector presents unique data privacy and security challenges. To meet these challenges, BGI Genomics actively maintains certifications like ISO/IEC 27001 and BS 10012 while complying with rigorous regulatory standards, including GDPR.
ISO/IEC 27001 is a comprehensive framework that dictates the requirements for an information security management system (ISMS), essential for protecting a company's financial data, intellectual property, and personal details entrusted by third parties. Meanwhile, BS 10012 specifically addresses the management of personal data, aligning with the stringent requirements of data protection regulations such as the GDPR.
In an insightful interview with AZoMedical, Dr. Fu Wei, Director of Quality Management at BGI Genomics, details the systematic and exhaustive process behind these certifications. This includes comprehensive audits involving document reviews, site visits, and management interviews, emphasizing the company's ongoing commitment to excellence and security.
BGI Genomics integrates quality management and privacy security into its operations, continuously updating its practices to adhere to the latest changes in ISO/IEC 27001, BS 10012, and GDPR regulations. Dr. Fu emphasizes the firm's strict adherence to these standards, stating, “BGI Genomics strictly follows the standards to set up and maintain information security and privacy management systems. The certification organizations review BGI Genomics's management systems on-site annually to ensure they work and continue to meet the standards and criteria.”
The impact of these certifications extends beyond meeting legal obligations; they foster enhanced trust with clients and partners. BGI Genomics updated its privacy policy and cookie policy earlier in the year. Its 2024 work plan includes significant updates to its information security management system. backup protocols for electronic records, and permission management for shared disks.
About Dr. Fu Wei
Dr. Fu Wei is the Director of the Quality Management Department at BGI Genomics. In 2018, the Shenzhen Association for Quality recognized him as a person of outstanding quality. He helped the BGI Europe laboratory in Denmark achieve ISO 15189 and ISO/IEC 27001 certifications.
About BGI Genomics
BGI Genomics, headquartered in Shenzhen, China, is the world's leading integrated solutions provider of precision medicine. Our services cover more than 100 countries and regions, involving more than 3,000 medical institutions. In July 2017, as a subsidiary of BGI Group, BGI Genomics (300676.SZ) was officially listed on the Shenzhen Stock Exchange.
END
Ensuring data security in biotechnology: strategies and challenges
2024-05-09
ELSE PRESS RELEASES FROM THIS DATE:
An entirely new COVID-related syndrome
2024-05-09
Pradipta Ghosh, M.D., sat down in her office at the University of California San Diego School of Medicine and considered a request from the other side of the world.
Ghosh, a professor in the Departments of Medicine and Cellular and Molecular Medicine at UC San Diego School of Medicine, received an email from Dennis McGonagle, Ph.D., professor of investigative rheumatology at the University of Leeds in the United Kingdom. It began an international collaboration, one that uncovered a previously overlooked ...
Improved wildfire smoke model identifies areas for public health intervention
2024-05-09
UNIVERSITY PARK, Pa. — The Canadian wildfires of June 2023 exposed a large portion of the Northeastern United States to unprecedented levels of smoke. A new model that combines wildfire smoke forecasts and data from ground-based sensors may help public health officials plan targeted interventions in areas most at risk for the negative health effects of unexpected smoke events and air pollution, according to a team led by Penn State scientists.
The researchers reported their findings in the journal Science of the Total Environment.
“Statistical analyses suggest that situations like last year’s ...
Highly drug-resistant infections from stem cell treatments in Mexico identified by National Jewish Health
2024-05-09
DENVER (May 9, 2024) – Experts in mycobacterial diseases at National Jewish Health, in collaboration with local health departments and the Centers for Disease Control and Prevention (CDC), are investigating a potential outbreak of a highly drug-resistant mycobacterium (germ) after U.S. patients who traveled to Mexico for stem cell injections became sick. Genetically identical Mycobacterium abscessus subspecies massiliense infections following stem cell injections at various clinics in Mexico prompted this investigation. Early results of the study were ...
Causal inference about the effects of interventions from observational studies in medical journals
2024-05-09
About The Study: Adoption of the proposed framework to identify when causal interpretation is appropriate in observational studies promises to facilitate better communication between authors, reviewers, editors, and readers. Practical implementation will require cooperation between editors, authors, and reviewers to operationalize the framework and evaluate its effect on the reporting of empirical research.
Corresponding Author: To contact the corresponding author, Issa J. Dahabreh, M.D., Sc.D., email idahabreh@hsph.harvard.edu.
To ...
Turning trash into treasure: breakthrough innovations in PET plastic upcycling
2024-05-09
A recent review has unveiled revolutionary methods to recycle and transform everyday polyethylene terephthalate (PET) plastic into valuable materials. By harnessing cutting-edge enzymes and catalysts, the review dramatically improves how we break down and reuse PET, slashing energy use and emissions. These game-changing techniques are poised to redefine plastic waste management and boost the circular economy.
Polyethylene terephthalate (PET) plastic into valuable materials. By harnessing cutting-edge PET, a prevalent form of plastic, poses significant environmental risks due to its durability and resistance to natural degradation. Traditional recycling methods often result in inferior-quality ...
Keck Medicine of USC launches institute to promote excellence in nursing
2024-05-09
LOS ANGELES — Keck Medicine of USC has launched the USC Nursing Institute to promote education, leadership development, clinical expertise and research among nurses.
The institute will support nurses across the health system’s four hospitals and more than 100 clinic locations to ensure nurses have access to the tools, education and training to provide exceptional patient care, facilitate collaboration and encourage career growth and leadership opportunities.
“Nurses are the backbone of our health system. The USC Nursing Institute supports a culture of excellence where nurses feel empowered to expand ...
Deep learning empowers reconfigurable intelligent surface in terahertz communication
2024-05-09
The escalating demand for wireless data traffic, driven by the proliferation of internet-of-things devices and broadband multimedia applications, has intensified the search for innovative solutions in wireless communication. A significant breakthrough has been reported in the application of reconfigurable intelligent surfaces for terahertz communications. In a research article published on Mar. 13 in Intelligent Computing, a team of researchers led by Zhen Gao of Beijing Institute of Technology has introduced a novel physical signal processing method that leverages deep learning to enhance ...
Scientists pinpoint new vaccine “booster” that promotes potent anti-tumour immunity
2024-05-09
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant – or “booster” – called C100 promotes potent anti-tumour immunity when it is injected directly into tumours in an animal model.
The scientists found that C100, derived from chitin – one of the most common building materials in nature, and which gives strength to the exoskeletons of crustaceans, insects, and the cell walls of fungi – is highly effective at stimulating a key sensing and signalling molecule which regulates ...
Study finds patients with limited English proficiency have poorer experiences with virtual health care
2024-05-09
People with limited English proficiency have a worse experience with virtual healthcare visits than those who are proficient in English, according to a new study led by a team of investigators at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system. The study highlights the importance of designing telehealth platforms and processes that better serve people who face day-to-day language barriers.
The study, published in JAMA Network Open, analyzed results ...
Declination of treatment, racial and ethnic disparity, and overall survival in patients with breast cancer
2024-05-09
About The Study: This cross-sectional study highlights racial and ethnic disparities in treatment declination and overall survival, suggesting the need for equity-focused interventions, such as patient education on treatment benefits and improved patient-clinician communication and shared decision-making, to reduce disparities and improve patient survival.
Corresponding Author: To contact the corresponding author, Dezheng Huo, M.D., Ph.D., email dhuo@bsd.uchicago.edu.
To ...